Sotera Health Company $SHC Stock Position Boosted by Two Seas Capital LP

Key Points

• Two Seas Capital LP increased its stake in Sotera Health Company by 14.7%, making it the firm's 7th largest position with 3,321,136 shares valued at approximately $38.7 million.
• Institutional investors own 91.03% of Sotera Health, indicating significant interest from large financial entities.
• Sotera Health reported better-than-expected earnings, with EPS of $0.20 for the quarter, surpassing estimates and achieving a year-over-year revenue increase of 6.4%.

Two Seas Capital LP lifted its position in shares of Sotera Health Company (NASDAQ:SHC - Free Report) by 14.7% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,321,136 shares of the company's stock after buying an additional 425,000 shares during the period. Sotera Health makes up approximately 1.2% of Two Seas Capital LP's portfolio, making the stock its 7th largest position. Two Seas Capital LP owned about 1.17% of Sotera Health worth $38,724,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Farther Finance Advisors LLC grew its position in Sotera Health by 4,881.9% in the first quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company's stock worth $70,000 after acquiring an additional 6,200 shares during the period. Teacher Retirement System of Texas purchased a new position in shares of Sotera Health during the 1st quarter worth $266,000. BNP Paribas Financial Markets acquired a new stake in shares of Sotera Health during the 4th quarter worth about $208,000. Principal Financial Group Inc. increased its position in shares of Sotera Health by 0.3% during the 1st quarter. Principal Financial Group Inc. now owns 352,388 shares of the company's stock worth $4,109,000 after purchasing an additional 1,037 shares during the last quarter. Finally, Ananym Capital Management LP purchased a new stake in Sotera Health in the 4th quarter valued at about $13,680,000. Hedge funds and other institutional investors own 91.03% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on SHC. Wall Street Zen raised shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. Barclays reaffirmed an "overweight" rating on shares of Sotera Health in a research report on Friday, August 8th. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $16.00.

Sotera Health Trading Down 0.2%

NASDAQ:SHC traded down $0.04 during trading hours on Friday, reaching $16.09. 516,631 shares of the stock were exchanged, compared to its average volume of 1,367,868. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 4.49. The business has a 50-day moving average of $13.69 and a two-hundred day moving average of $12.42. Sotera Health Company has a twelve month low of $9.53 and a twelve month high of $16.99. The company has a market capitalization of $4.57 billion, a price-to-earnings ratio of 200.96 and a beta of 1.84.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings results on Friday, August 8th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.03. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The company had revenue of $294.34 million for the quarter, compared to analysts' expectations of $275.81 million. During the same period in the prior year, the firm earned $0.19 earnings per share. The firm's revenue was up 6.4% compared to the same quarter last year. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. On average, equities analysts predict that Sotera Health Company will post 0.61 EPS for the current year.

Insider Transactions at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 8,000,000 shares of the company's stock in a transaction on Friday, September 5th. The stock was sold at an average price of $15.11, for a total transaction of $120,880,000.00. Following the sale, the director owned 41,215,301 shares of the company's stock, valued at approximately $622,763,198.11. This represents a 16.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michael P. Rutz sold 126,611 shares of the company's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $16.38, for a total value of $2,073,888.18. Following the sale, the insider directly owned 450,204 shares in the company, valued at $7,374,341.52. This represents a 21.95% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 20,126,611 shares of company stock valued at $304,273,888. 47.55% of the stock is currently owned by company insiders.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.